|
Sanchez-Villalobos M, Campos Banos E, Martinez-Balsalobre E, Navarro-Ramirez V, Videla MAB, Pinilla M, Guillen-Navarro E, Salido-Fierrez E, Perez-Oliva AB. Whole Blood Transcriptome Analysis in Congenital Anemia Patients. Int J Mol Sci. 2024 Oct 31;25(21):11706. doi: 10.3390/ijms252111706. PubMed PMID: 39519257; PubMed Central PMCID: PMC11546763.
AÑO: 2024; IF: 4.9
|
39519257
|
Rodriguez-Ruiz L, Lozano-Gil JM, Naranjo-Sanchez E, Martinez-Balsalobre E, Martinez-Lopez A, Lachaud C, Blanquer M, Phung TK, Garcia-Moreno D, Cayuela ML, Tyrkalska SD, Perez-Oliva AB, Mulero V. ZAKalpha/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome. EMBO Mol Med. 2023 Oct 11;15(10):e18142. doi: 10.15252/emmm.202318142. Epub 2023 Sep 7. PubMed PMID: 37675820; PubMed Central PMCID: PMC10565642.
AÑO: 2023; IF: 9.0
|
|
Peris I, Romero-Murillo S, Martinez-Balsalobre E, Farrington CC, Arriazu E, Marcotegui N, Jimenez-Munoz M, Alburquerque-Prieto C, Torres-Lopez A, Fresquet V, Martinez-Climent JA, Mateos MC, Cayuela ML, Narla G, Odero MD, Vicente C. Activation of the PP2A-B56alpha heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation. Blood. 2023 Mar 2;141(9):1047-1059. doi: 10.1182/blood.2022016466. PubMed PMID: 36455198; PubMed Central PMCID: PMC10023731.
AÑO: 2023; IF: 21.0
|
|
Martinez-Balsalobre E, Guervilly JH, van Asbeck-van der Wijst J, Perez-Oliva AB, Lachaud C. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer? Blood Rev. 2023 Jul;60:101094. doi: 10.1016/j.blre.2023.101094. Epub 2023 Apr 28. PubMed PMID: 37142543.
AÑO: 2023; IF: 6.9
|
|
Martinez-Balsalobre E, Garcia-Castillo J, Garcia-Moreno D, Naranjo-Sanchez E, Fernandez-Lajarin M, Blasco MA, Alcaraz-Perez F, Mulero V, Cayuela ML. Telomerase RNA-based aptamers restore defective myelopoiesis in congenital neutropenic syndromes. Nat Commun. 2023 Sep 22;14(1):5912. doi: 10.1038/s41467-023-41472-7. PubMed PMID: 37737237; PubMed Central PMCID: PMC10516865.
AÑO: 2023; IF: 14.7
|